Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3.

Kreyling WG, Holzwarth U, Haberl N, Kozempel J, Wenk A, Hirn S, Schleh C, Schäffler M, Lipka J, Semmler-Behnke M, Gibson N.

Nanotoxicology. 2017 May;11(4):454-464. doi: 10.1080/17435390.2017.1306894. Epub 2017 Apr 3.

PMID:
28290735
2.

Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2.

Kreyling WG, Holzwarth U, Schleh C, Kozempel J, Wenk A, Haberl N, Hirn S, Schäffler M, Lipka J, Semmler-Behnke M, Gibson N.

Nanotoxicology. 2017 May;11(4):443-453. doi: 10.1080/17435390.2017.1306893. Epub 2017 Apr 3.

PMID:
28290734
3.

Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1.

Kreyling WG, Holzwarth U, Haberl N, Kozempel J, Hirn S, Wenk A, Schleh C, Schäffler M, Lipka J, Semmler-Behnke M, Gibson N.

Nanotoxicology. 2017 May;11(4):434-442. doi: 10.1080/17435390.2017.1306892. Epub 2017 Apr 3.

PMID:
28290717
4.

Biokinetic datasets of PEI F25-LMW complexed and non-complexed 32P-siRNA within different lung compartments.

Lipka J, Semmler-Behnke M, Wenk A, Burkhardt J, Aigner A, Kreyling W.

Data Brief. 2016 Apr 1;7:1175-1178. eCollection 2016 Jun.

5.

Kinesin-Binding Protein Controls Microtubule Dynamics and Cargo Trafficking by Regulating Kinesin Motor Activity.

Kevenaar JT, Bianchi S, van Spronsen M, Olieric N, Lipka J, Frias CP, Mikhaylova M, Harterink M, Keijzer N, Wulf PS, Hilbert M, Kapitein LC, de Graaff E, Ahkmanova A, Steinmetz MO, Hoogenraad CC.

Curr Biol. 2016 Apr 4;26(7):849-61. doi: 10.1016/j.cub.2016.01.048. Epub 2016 Mar 3.

6.

Biokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into mice.

Lipka J, Semmler-Behnke M, Wenk A, Burkhardt J, Aigner A, Kreyling W.

Int J Pharm. 2016 Mar 16;500(1-2):227-35. doi: 10.1016/j.ijpharm.2016.01.038. Epub 2016 Jan 21.

PMID:
26802492
7.

Microtubule-binding protein doublecortin-like kinase 1 (DCLK1) guides kinesin-3-mediated cargo transport to dendrites.

Lipka J, Kapitein LC, Jaworski J, Hoogenraad CC.

EMBO J. 2016 Feb 1;35(3):302-18. doi: 10.15252/embj.201592929. Epub 2016 Jan 12.

8.

Positioning of AMPA Receptor-Containing Endosomes Regulates Synapse Architecture.

Esteves da Silva M, Adrian M, Schätzle P, Lipka J, Watanabe T, Cho S, Futai K, Wierenga CJ, Kapitein LC, Hoogenraad CC.

Cell Rep. 2015 Nov 3;13(5):933-43. doi: 10.1016/j.celrep.2015.09.062. Epub 2015 Oct 22.

9.

The GRIP1/14-3-3 pathway coordinates cargo trafficking and dendrite development.

Geiger JC, Lipka J, Segura I, Hoyer S, Schlager MA, Wulf PS, Weinges S, Demmers J, Hoogenraad CC, Acker-Palmer A.

Dev Cell. 2014 Feb 24;28(4):381-93. doi: 10.1016/j.devcel.2014.01.018.

10.

Effects of cognitive-behavioral therapy on brain responses to subliminal and supraliminal threat and their functional significance in specific phobia.

Lipka J, Hoffmann M, Miltner WH, Straube T.

Biol Psychiatry. 2014 Dec 1;76(11):869-77. doi: 10.1016/j.biopsych.2013.11.008. Epub 2013 Nov 14.

PMID:
24393393
11.

Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat.

Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schäffler M, Tian F, Schmid G, Oberdörster G, Kreyling WG.

Part Fibre Toxicol. 2014 Sep 10;11:33. doi: 10.1186/s12989-014-0033-9.

12.

Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size.

Kreyling WG, Hirn S, Möller W, Schleh C, Wenk A, Celik G, Lipka J, Schäffler M, Haberl N, Johnston BD, Sperling R, Schmid G, Simon U, Parak WJ, Semmler-Behnke M.

ACS Nano. 2014 Jan 28;8(1):222-33. doi: 10.1021/nn403256v. Epub 2013 Dec 30.

13.

Mutations in cytoplasmic dynein and its regulators cause malformations of cortical development and neurodegenerative diseases.

Lipka J, Kuijpers M, Jaworski J, Hoogenraad CC.

Biochem Soc Trans. 2013 Dec;41(6):1605-12. doi: 10.1042/BST20130188. Review.

PMID:
24256262
14.

Myosin-V opposes microtubule-based cargo transport and drives directional motility on cortical actin.

Kapitein LC, van Bergeijk P, Lipka J, Keijzer N, Wulf PS, Katrukha EA, Akhmanova A, Hoogenraad CC.

Curr Biol. 2013 May 6;23(9):828-34. doi: 10.1016/j.cub.2013.03.068. Epub 2013 Apr 18.

15.

TRAK/Milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites.

van Spronsen M, Mikhaylova M, Lipka J, Schlager MA, van den Heuvel DJ, Kuijpers M, Wulf PS, Keijzer N, Demmers J, Kapitein LC, Jaarsma D, Gerritsen HC, Akhmanova A, Hoogenraad CC.

Neuron. 2013 Feb 6;77(3):485-502. doi: 10.1016/j.neuron.2012.11.027.

16.
17.

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.

Vazquez JA, González Patzán LD, Stricklin D, Duttaroy DD, Kreidly Z, Lipka J, Sable C.

Curr Med Res Opin. 2012 Dec;28(12):1921-31. doi: 10.1185/03007995.2012.748653. Epub 2012 Nov 21.

PMID:
23145859
18.

Awareness modulates responses of the amygdala and the visual cortex to highly arousing visual threat.

Hoffmann M, Lipka J, Mothes-Lasch M, Miltner WH, Straube T.

Neuroimage. 2012 Sep;62(3):1439-44. doi: 10.1016/j.neuroimage.2012.05.064. Epub 2012 Jun 1.

PMID:
22659485
19.

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): results of two Phase I studies.

Harro CD, Betts RF, Hartzel JS, Onorato MT, Lipka J, Smugar SS, Kartsonis NA.

Vaccine. 2012 Feb 21;30(9):1729-36. doi: 10.1016/j.vaccine.2011.12.045. Epub 2011 Dec 20.

PMID:
22192849
20.

[Knowledge of BLS and AED resuscitation algorithm amongst medical students--preliminary results].

Chojnacki P, Ilieva R, Kołodziej A, Królikowska A, Lipka J, Ruta J.

Anestezjol Intens Ter. 2011 Jan-Mar;43(1):29-32. Polish.

PMID:
21786527
21.

Vigilance for threat interacts with amygdala responses to subliminal threat cues in specific phobia.

Lipka J, Miltner WH, Straube T.

Biol Psychiatry. 2011 Sep 1;70(5):472-8. doi: 10.1016/j.biopsych.2011.04.005. Epub 2011 May 24.

PMID:
21601831
22.

Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.

Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schäffler M, Schmid G, Simon U, Kreyling WG.

Nanotoxicology. 2012 Feb;6(1):36-46. doi: 10.3109/17435390.2011.552811. Epub 2011 Feb 10.

23.

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.

Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG.

Eur J Pharm Biopharm. 2011 Apr;77(3):407-16. doi: 10.1016/j.ejpb.2010.12.029. Epub 2010 Dec 31.

24.

Amygdala activation to threat under attentional load in individuals with anxiety disorder.

Straube T, Lipka J, Sauer A, Mothes-Lasch M, Miltner WH.

Biol Mood Anxiety Disord. 2011 Dec 16;1(1):12. doi: 10.1186/2045-5380-1-12.

25.

Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.

Günther M, Lipka J, Malek A, Gutsch D, Kreyling W, Aigner A.

Eur J Pharm Biopharm. 2011 Apr;77(3):438-49. doi: 10.1016/j.ejpb.2010.11.007. Epub 2010 Nov 18. Review.

PMID:
21093588
26.

Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Harro C, Betts R, Orenstein W, Kwak EJ, Greenberg HE, Onorato MT, Hartzel J, Lipka J, DiNubile MJ, Kartsonis N.

Clin Vaccine Immunol. 2010 Dec;17(12):1868-74. doi: 10.1128/CVI.00356-10. Epub 2010 Oct 13.

27.

Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.

Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG.

Biomaterials. 2010 Sep;31(25):6574-81. doi: 10.1016/j.biomaterials.2010.05.009. Epub 2010 Jun 9.

PMID:
20542560
28.

Dosimetry and toxicology of inhaled ultrafine particles.

Schmid O, Möller W, Semmler-Behnke M, Ferron GA, Karg E, Lipka J, Schulz H, Kreyling WG, Stoeger T.

Biomarkers. 2009 Jul;14 Suppl 1:67-73. doi: 10.1080/13547500902965617. Review.

PMID:
19604063
29.

Neural representation of anxiety and personality during exposure to anxiety-provoking and neutral scenes from scary movies.

Straube T, Preissler S, Lipka J, Hewig J, Mentzel HJ, Miltner WH.

Hum Brain Mapp. 2010 Jan;31(1):36-47. doi: 10.1002/hbm.20843.

PMID:
19585588
30.

Biodistribution of 1.4- and 18-nm gold particles in rats.

Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W.

Small. 2008 Dec;4(12):2108-11. doi: 10.1002/smll.200800922. No abstract available.

PMID:
19031432
31.

Bipolar radiofrequency ablation: is the shape of the coagulation volume different in comparison to monopolar RF-ablation using variable active tip lengths?

Bruners P, Lipka J, Günther RW, Schmitz-Rode T, Mahnken AH.

Minim Invasive Ther Allied Technol. 2008;17(5):267-74. doi: 10.1080/13645700802384122.

PMID:
18855208
32.

Caspofungin for the treatment of less common forms of invasive candidiasis.

Cornely OA, Lasso M, Betts R, Klimko N, Vazquez J, Dobb G, Velez J, Williams-Diaz A, Lipka J, Taylor A, Sable C, Kartsonis N.

J Antimicrob Chemother. 2007 Aug;60(2):363-9. Epub 2007 May 26.

PMID:
17526917
33.

The use of contaminated donor organs in transplantation.

Zibari GB, Lipka J, Zizzi H, Abreo KD, Jacobbi L, McDonald JC.

Clin Transplant. 2000 Aug;14(4 Pt 2):397-400.

PMID:
10946778
34.

Spontaneous bacterial peritonitis in liver failure.

Lipka JM, Zibari GB, Dies DF, McMillan RW, Aultman DF, McDonald JC.

Am Surg. 1998 Dec;64(12):1155-7.

PMID:
9843334
35.

[Prognosis and outcome of idiopathic dilatation of the right atrium in children. A cooperative study of 15 cases].

Blaysat G, Villain E, Marçon F, Rey C, Lipka J, Lefèvre M, Bourlon F.

Arch Mal Coeur Vaiss. 1997 May;90(5):645-8. French.

PMID:
9295945
36.

Human T lymphotropic virus type I/II in Lake Lindu Valley, Central Sulawesi, Indonesia.

Lal RB, Lipka JJ, Foung SK, Hadlock KG, Reyes GR, Carney WP.

J Acquir Immune Defic Syndr. 1993 Sep;6(9):1067-8. No abstract available.

PMID:
8340898
37.

Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.

Lal RB, Buckner C, Khabbaz RF, Kaplan JE, Reyes G, Hadlock K, Lipka J, Foung SK, Chan L, Coligan JE.

Clin Immunol Immunopathol. 1993 Apr;67(1):40-9.

PMID:
7680300
38.

Biomechanical study of C1-C2 posterior arthrodesis techniques.

Hajek PD, Lipka J, Hartline P, Saha S, Albright JA.

Spine (Phila Pa 1976). 1993 Feb;18(2):173-7.

PMID:
8441930
39.

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

Roberts BD, Foung SK, Lipka JJ, Kaplan JE, Hadlock KG, Reyes GR, Chan L, Heneine W, Khabbaz RF.

J Clin Microbiol. 1993 Feb;31(2):260-4.

40.

Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.

Buckner C, Roberts CR, Foung SK, Lipka J, Reyes GR, Hadlock K, Chan L, Gongora-Biachi RA, Hjelle B, Lal RB.

J Infect Dis. 1992 Nov;166(5):1160-3.

PMID:
1383353
41.

Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II.

Hadlock KG, Lipka JJ, Chow TP, Foung SK, Reyes GR.

Blood. 1992 May 15;79(10):2789-96.

PMID:
1375112
42.

Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.

Rudolph DL, Yee J, Mone J, Foung SK, Lipka JJ, Reyes GR, Hadlock K, Chan L, Villinger F, Lairmore MD, et al.

J Clin Microbiol. 1992 Apr;30(4):858-61.

43.

Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.

Lipka JJ, Miyoshi I, Hadlock KG, Reyes GR, Chow TP, Blattner WA, Shaw GM, Hanson CV, Gallo D, Chan L, et al.

J Infect Dis. 1992 Feb;165(2):268-72.

PMID:
1370526
44.

Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.

Lipka JJ, Santiago P, Chan L, Reyes GR, Samuel KP, Blattner WA, Shaw GM, Hanson CV, Sninsky JJ, Foung SK.

J Infect Dis. 1991 Aug;164(2):400-3.

PMID:
1856487
45.

HTLV-I-associated myelopathy in a Californian: diagnosis by reactivity to a viral recombinant antigen.

Honig LS, Lipka JJ, Young KY, Weiss JH, Foung SK.

Neurology. 1991 Mar;41(3):448-50.

PMID:
1706492
46.

Laser flash photolysis studies of the reduction kinetics of NADPH:cytochrome P-450 reductase.

Bhattacharyya AK, Lipka JJ, Waskell L, Tollin G.

Biochemistry. 1991 Jan 22;30(3):759-65.

PMID:
1899033
47.

Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals.

Lipka JJ, Young KK, Kwok SY, Reyes GR, Sninsky JJ, Foung SK.

Vox Sang. 1991;61(3):171-6.

PMID:
1725466
48.

Mass spectrometric analysis of rabbit and bovine trypsin-solubilized cytochrome b5.

Gibson BW, Falick AM, Lipka JJ, Waskell LA.

J Protein Chem. 1990 Dec;9(6):695-703.

PMID:
2073321
49.

A high-resolution tungstate membrane label.

Hainfeld JF, Lipka JJ, Quaite FE.

J Histochem Cytochem. 1990 Dec;38(12):1795-803.

PMID:
1701459
50.

Eleven tungsten atom cluster labels: high-resolution, site-specific probes for electron microscopy.

Hainfeld JF, Foley CJ, Maelia LE, Lipka JJ.

J Histochem Cytochem. 1990 Dec;38(12):1787-93.

PMID:
1701458

Supplemental Content

Support Center